American journal of hematology · 2007
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yoo Changhoon, Ryu Min-Hee, Huh Jooryung, Park Ji Hyun, Kang Hye Jin, Ahn Hyo Sook, Lee Yongjae, Kim Myoung Joon, Lee Hyoungnam, Kim Tae Won, Chang Heung Moon, Lee Jae-Lyun, Kang Yoon-Koo
Аннотация
Ocular adnexal lymphoma (OAL) is a mostly extranodal marginal zone lymphoma (EMZL). Recent findings have suggested an association between Chlamydia psittaci (Cp) infection and OAL. We sought to confirm this issue and to analyze the clinicopathologic characteristics of OAL in Korea. Between 1993 and 2004, 33 OAL cases were identified at the Asan Medical Center, Seoul, Korea. DNA was extracted from paraffin-embedded tissues, and touchdown enzyme time release polymerase chain reaction was performed to identify three Chlamydia species (Cp, C. tracomatis, and C. pneumoniae). The same procedures were also performed in 21 samples from patients with non-neoplastic ocular adnexal disease (NNOAD). All OAL cases were EMZL. Cp DNA was detected in 26/33 (79%) OAL samples compared with 5/21 (23%) NNOAD samples (P < 0.001). With a median follow-up of 38.5 months (range: 1-105 months), the 5-year progression-free survival (PFS) and overall survival (OS) rates of OAL patients were 72% and 93%, respectively. Clinicopathologic characteristics, recurrence rate, PFS, and OS were not associated with Cp infection. Our study demonstrates an association between OAL and Cp infection in Korea, suggesting that Cp plays a role as a causative antigen in Korean OAL patients.
Предметные рубрики MeSH
Antineoplastic Combined Chemotherapy ProtocolsCase-Control StudiesChlamydophila psittaciCisplatinCombined Modality TherapyCyclophosphamideCytarabineDNA, BacterialDexamethasoneDisease-Free SurvivalDose-Response Relationship, DrugDose-Response Relationship, RadiationDoxorubicinEtoposideEye NeoplasmsFollow-Up StudiesHumansKoreaLymphoma, B-CellPolymerase Chain ReactionPrednisonePsittacosisRetrospective StudiesSecondary PreventionSequence Analysis, DNATime FactorsVincristine